2015
DOI: 10.1016/j.bbr.2015.06.010
|View full text |Cite
|
Sign up to set email alerts
|

Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL/6J mice

Abstract: Overall, these data suggest exogenous RXFP3 agonists can reduce elevated (FG-7142-induced) levels of anxiety in mice; data important for gauging how conserved such effects are, with a view to modelling human pathophysiology and the likely therapeutic potential of RXFP3-targeted drugs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
31
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 45 publications
(34 citation statements)
references
References 72 publications
2
31
0
1
Order By: Relevance
“…This, in turn, could produce impaired learning and memory, via effects within the directly targeted hippocampus and via remote, relayed effects in the MS/DB. Further studies are required to explore this hypothesis, including an examination of the effect of RXFP3 activation by validated RXFP3‐specific agonist peptides (Liu et al, ; Shabanpoor et al, ; Zhang et al, ) on DG hilus SST neuron activity, perhaps in a strain of SST reporter mice (Ma et al, ; Peng et al, ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This, in turn, could produce impaired learning and memory, via effects within the directly targeted hippocampus and via remote, relayed effects in the MS/DB. Further studies are required to explore this hypothesis, including an examination of the effect of RXFP3 activation by validated RXFP3‐specific agonist peptides (Liu et al, ; Shabanpoor et al, ; Zhang et al, ) on DG hilus SST neuron activity, perhaps in a strain of SST reporter mice (Ma et al, ; Peng et al, ).…”
Section: Discussionmentioning
confidence: 99%
“…However, the viral injections in the present study did not cover the entire dorsoventral extent of the DG hilus in ventral hippocampus, reducing the likelihood of observing an effect on anxiety‐like behavior. The RLN3/RXFP3 system in mice and rats has been shown to be involved in stress responses (Tanaka et al, ; Banerjee et al, ) and modulation of anxiety‐like behavior (Ryan et al, ; Zhang et al, ), with pronounced changes in RLN3 mRNA expression and RLN3‐IR levels in response to stressors (Tanaka et al, ; Lenglos et al, ; Ma et al, ; Walker et al, ; Calvez et al, ). Therefore, further studies with more extensive and/or focused depletion of RXFP3 in ventral hippocampus are warranted.…”
Section: Discussionmentioning
confidence: 99%
“…Our future goals are to identify the source of these glutamatergic inputs and to determine if pharmacological RXFP3 activation can attenuate HPA axis activity via these inputs in vivo. Additionally, recent studies indicate that it would be of interest to determine whether RXFP3 modulation is able to influence the HPA axis via direct or indirect mechanisms under different in vivo conditions, such as after a chronic stress protocol (Walker et al 2015;Zhang et al 2015), to further explore the plasticity and capability of RXFP3 signalling beyond basal conditions. Psychopharmacology…”
Section: Discussionmentioning
confidence: 99%
“…Injections (1 μL) were made via an injector protruding beyond the guide cannulae into the target area as described above. Doses and timing of experiments were based on studies using the same peptide in rats and mice (Ryan et al 2013a;Smith et al 2014a;Zhang et al 2015).…”
Section: Peptide Injectionsmentioning
confidence: 99%
“…NI neurons expressing relaxin-3 are highly responsive to stress signals (Tanaka et al, 2005), whereas relaxin-3 projections into the septohippocampal system/pathway modulates memory (Ma et al, 2009). Stimulating the relaxin-3 signaling system is beneficial for reducing anxiety-like behavior (Zhang et al, 2015a). RXFP3 is expressed in neurons in the paraventricular region of the hypothalamus (Liu et al, 2003;Ma et al, 2007;Smith et al, 2010), and stimulation of these neurons with relaxin-3 agonists or antagonists regulates appetite in rodent models.…”
Section: Introductionmentioning
confidence: 99%